The role of drug use outcome expectancies in substance abuse risk: an interactional-transformational model

Addictive Behaviors
Adam M Leventhal, Joy M Schmitz

Abstract

While a variety of risk factors for substance abuse have been identified, the psychological mechanisms underlying the transmission of risk is unclear based on studies using traditional risk-outcome research designs. The present paper identifies drug use outcome expectancies as a common etiological mechanism involved in substance abuse risk. Existing literature findings are reviewed and integrated according to an interactional-transformational (IT) model of developmental psychopathology. This model identifies the preliminary (mediating) and secondary (moderating) role of drug expectancies as important operations involved in the development of substance use patterns. Advantages of the IT model over traditional trait-based or environmental models are discussed, along with implications for intervention and future research.

References

Oct 1, 1992·Alcoholism, Clinical and Experimental Research·T L WallC L Ehlers
Sep 1, 1992·American Journal of Public Health·S L Bailey
Oct 1, 1990·Journal of Personality and Social Psychology·S J FrankM Tuer
Jul 1, 1990·Journal of Studies on Alcohol·P M MillerM S Goldman
May 1, 1989·Journal of Studies on Alcohol·B C Leigh
Jan 1, 1987·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·L D JohnstonJ G Bachman
Aug 1, 1988·Alcoholism, Clinical and Experimental Research·C R CloningerM Bohman
Feb 1, 1988·British Journal of Addiction·S CasswellP Brasch
May 1, 1987·Journal of Abnormal Psychology·S A BrownB A Stetson
Jun 1, 1985·British Journal of Addiction·E M Adlaf, R G Smart
Feb 1, 1985·Journal of Consulting and Clinical Psychology·S A Brown
Aug 1, 1980·Journal of Consulting and Clinical Psychology·S A BrownL R Anderson
Mar 1, 1993·Trends in Neurosciences·G UhlS Smith
Jul 1, 1994·The International Journal of the Addictions·J Moore
Feb 1, 1994·Journal of Abnormal Child Psychology·J E Turner, D A Cole
Jan 1, 1994·Journal of Studies on Alcohol·M A Schuckit
Feb 1, 1996·Alcoholism, Clinical and Experimental Research·K R WeingardtB C Leigh
Nov 1, 1996·Journal of Abnormal Psychology·Kenneth J SherGail Raskin
Jul 22, 1998·Psychological Bulletin·B F Chorpita, D H Barlow
Mar 11, 2000·Journal of Consulting and Clinical Psychology·D G KilpatrickP P Schnurr
Feb 7, 2001·Annual Review of Psychology·G Margolin, E B Gordis
Nov 15, 2001·Alcoholism, Clinical and Experimental Research·D M McCarthyT L Wall
May 25, 2002·The American Journal on Addictions·Wilson M ComptonEdward L Spitznagel
Mar 29, 2003·Social Psychiatry and Psychiatric Epidemiology·Carolyn D M Furr-Holden, James C Anthony
Jun 6, 2003·Addictive Behaviors·Kevin P ConwayKathleen Ries Merikangas
Jun 11, 2003·Journal of Consulting and Clinical Psychology·Iris Y Cruz, Michael E Dunn
Jun 20, 2003·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Dara R Musher-Eizenman, Alexis D Kulick
Jun 24, 2003·Journal of Studies on Alcohol·Susan F TapertSandra A Brown
Aug 28, 2003·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Andrew J WatersMark H Balabanis
Aug 28, 2003·Experimental and Clinical Psychopharmacology·Amy L Copeland, Colleen E Carney
Feb 11, 2004·Experimental and Clinical Psychopharmacology·Jack DarkesMark S Goldman
Mar 17, 2004·Psychological Assessment·Mark S Goldman, Jack Darkes

❮ Previous
Next ❯

Citations

Dec 5, 2009·Psychopharmacology·Lee HogarthTheodora Duka
Mar 25, 2011·Attention Deficit and Hyperactivity Disorders·Kerrie GlassBenjamin L Hankin
Sep 30, 2010·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·A K RoseM Hobbs
Feb 13, 2016·The American Journal on Addictions·Nicholas I GoldensonAdam M Leventhal
Apr 22, 2009·American Journal of Community Psychology·Sarah DiamondDamion Sincere Morgan
May 1, 2013·Addiction·Matthew Tyler BodenMarcel O Bonn-Miller
Jul 16, 2015·Addiction·Paul T HarrellThomas H Brandon
Aug 30, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Paul T HarrellThomas H Brandon
May 3, 2014·Journal of Addictive Diseases·Raina D PangAdam M Leventhal
Jul 13, 2017·Journal of Psychoactive Drugs·Samantha J LookatchTodd M Moore
Jan 30, 2018·Journal of Psychoactive Drugs·Alireza NorooziAfarin Rahimi-Movaghar
Mar 12, 2008·Substance Abuse Treatment, Prevention, and Policy·Andrea Petróczi, Eugene Aidman
Jul 30, 2019·Addiction·Matt Field, Inge Kersbergen
Aug 11, 2020·Journal of Psychoactive Drugs·Patricia A GoodhinesAesoon Park
May 26, 2020·Substance Use & Misuse·Christina ScharmerMitchell Earleywine
Aug 29, 2019·Substance Abuse : Research and Treatment·Paul T HarrellGwendolyn P Quinn
Oct 18, 2016·The American Journal on Addictions·David S MathaiThomas R Kosten
Mar 26, 2014·Journal of Addiction Medicine·Casey R GuillotAdam M Leventhal
Oct 19, 2019·BMC Public Health·Chao-Ming ChangWei J Chen
Feb 10, 2021·Child Psychiatry and Human Development·Enrique López-RamírezOlga Inozemtseva
Apr 20, 2021·Substance Use & Misuse·Kelly E GreenSamantha N Natal
Apr 24, 2021·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Anne C FernandezFrederic Blow
Jul 17, 2021·Journal of American College Health : J of ACH·Alynna G Summit, Nora E Noel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.